Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)
China flag China · Delayed Price · Currency is CNY
27.76
+0.28 (1.02%)
Feb 3, 2026, 3:04 PM CST

SHE:300357 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Operating Revenue
1,045921.46840.75894.88804.12633.42
Other Revenue
3.943.947.441.143.582.79
1,049925.39848.19896.02807.69636.21
Revenue Growth (YoY)
15.90%9.10%-5.34%10.94%26.95%-0.49%
Cost of Revenue
49.6544.8140.1942.5134.4428.54
Gross Profit
998.87880.58808853.5773.25607.67
Selling, General & Admin
461.41434.65385.28359.63333.97263.18
Research & Development
117.72119.88112.2106.0287.9361.27
Other Operating Expenses
18.977.844.574.533.783.27
Operating Expenses
600.05563.23501.05471.43427.23328.01
Operating Income
398.82317.36306.95382.07346.02279.66
Interest Expense
-0.76-1.06-1.31-0.44-0.36-
Interest & Investment Income
26.8735.8132.8728.3529.0324.63
Currency Exchange Gain (Loss)
000-0-0-0.01
Other Non Operating Income (Expenses)
2.44-0.34-0.26-0.15-0.17-0.17
EBT Excluding Unusual Items
427.36351.76338.25409.82374.52304.11
Gain (Loss) on Sale of Investments
4.822.43-0.67-0.88-0.12.66
Gain (Loss) on Sale of Assets
0.630.57--0.27--
Asset Writedown
-1.42-1.42-0.58-43.23-0.1-0.01
Other Unusual Items
14.4111.728.9533.318.6715.85
Pretax Income
445.82365.06345.96398.75393322.62
Income Tax Expense
68.7460.7250.4363.0266.7152.89
Earnings From Continuing Operations
377.08304.34295.52335.73326.29269.72
Minority Interest in Earnings
13.3613.4814.6613.0511.78.72
Net Income
390.43317.82310.18348.77337.99278.45
Net Income to Common
390.43317.82310.18348.77337.99278.45
Net Income Growth
25.02%2.46%-11.06%3.19%21.38%-6.65%
Shares Outstanding (Basic)
524524524524524524
Shares Outstanding (Diluted)
524524524524524524
Shares Change (YoY)
-0.01%-0.00%--0.00%0.00%-0.00%
EPS (Basic)
0.750.610.590.670.650.53
EPS (Diluted)
0.750.610.590.670.650.53
EPS Growth
25.03%2.46%-11.06%3.19%21.38%-6.65%
Free Cash Flow
246.92133.12154.61159.62236.33186.06
Free Cash Flow Per Share
0.470.250.290.300.450.35
Dividend Per Share
0.2200.2200.1850.2000.2010.160
Dividend Growth
-22.81%18.92%-7.50%-0.50%25.62%-11.11%
Gross Margin
95.27%95.16%95.26%95.25%95.74%95.51%
Operating Margin
38.04%34.29%36.19%42.64%42.84%43.96%
Profit Margin
37.24%34.34%36.57%38.92%41.85%43.77%
Free Cash Flow Margin
23.55%14.39%18.23%17.82%29.26%29.25%
EBITDA
451.29360.81338.38402.44366.11294.68
EBITDA Margin
43.04%38.99%39.89%44.91%45.33%46.32%
D&A For EBITDA
52.4743.4531.4320.3720.0815.03
EBIT
398.82317.36306.95382.07346.02279.66
EBIT Margin
38.04%34.29%36.19%42.64%42.84%43.96%
Effective Tax Rate
15.42%16.63%14.58%15.80%16.97%16.39%
Revenue as Reported
1,049925.39848.19896.02807.69636.21
Source: S&P Global Market Intelligence. Standard template. Financial Sources.